Insulin, Lente [inzulin lente]
- Terms
-
inzulin Monotard Novo
monokomponentní inzulin lente
Monotard
-
Insulin Novo Monotard
Insulin, Lente, Monocomponent
Insulin, Monotard
An insulin, zinc chloride preparation in the form of a suspension of crystals and amorphous material in a ratio of approximately 7:3. Typically, lente insulin has a duration of activity that lasts between 13-20 hours after dosage.
- DUI
- D061405 MeSH Browser
- CUI
- M0011437
- Previous indexing
- Insulin, Long-Acting (1966-2011)
- History note
- 2012; use INSULIN, LONG-ACTING 1966-2011; for INSULIN, LENTE, MONOCOMPONENT use INSULIN, LONG-ACTING 1983-2011; for INSULIN, MONTARD and INSULIN NOVO MONOTARD use INSULIN, LONG-ACTING 1984-2011
- Public note
- 2012; see INSULIN, LONG-ACTING 1966-2011; for INSULIN, LENTE, MONOCOMPONENT see INSULIN, LONG-ACTING 1983-2011; for INSULIN, MONTARD and INSULIN NOVO MONOTARD see INSULIN, LONG-ACTING 1984-2011
Combination
- antagonists & inhibitors
- Insulin Antagonists
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AN
- analysis
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
insulin, lente, pork Chemical MeSH Browser